Page 2 - Piramal Enterprises

Piramal Foundation runs campaign to dispel vax hesitancy in tribal dists

Campaign Aashwasan -implemented along with Union Health and Tribal Affairs Ministries as well as USAID- aims to cover all villages of blocks with over 25% of tribal population in 177 tribal districts

Piramal Enterprises to raise Rs 500 cr via non-convertible debentures

The debentures are proposed to be listed on debt segment and capital market segment of National Stock Exchange (NSE) and BSE Ltd, it added

Piramal Enterprises Q3 profit rises 11% to Rs 888 crore

The company had posted a net profit of Rs 799 crore for the same period last fiscal year

Rupen Jhaveri appointed Group President of Piramal Enterprises

Piramal Enterprises Limited (PEL) on Wednesday announced the appointment of Rupen Jhaveri as its Group President, with primary focus on financial services. In the newly created role, Jhaveri will be responsible for business development, strategy, merger and acquisition, capital allocation and corporate finance. The appointment is effective January 24, 2022, the company said in a statement. His appointment is following the company's announcement in October 2021 that it would demerge its financial services and pharmaceuticals operations, aimed at simplifying PEL's corporate structure and unlocking value. Post the demerger, PEL will become one of the largest diversified NBFCs with capabilities in affordable home lending, small business lending, construction finance and digital embedded finance, the company said. Jhaveri joins PEL from global investment firm KKR, where he was a managing director at its India private equity team. Prior to joining KKR, he was with Goldman Sachs & Co in .

Piramal OTC aims to double turnover to Rs 1,000 cr in three years

PEL's Pharma and financial services arms demerger is expected to be completed over next 3 quarters

Piramal Enterprises consolidated net profit down 32% to Rs 426 crore

The total income for the reporting quarter was down 3 per cent to Rs 3,234 crore from Rs 3,339 crore in Q2FY21

Piramal Enterprises Q2 net profit declines 32% to Rs 426 crore

Piramal Enterprises on Thursday reported a 32.12 per cent decline in consolidated net profit at Rs 426.49 crore for the quarter ended September

Piramal Ent dips 5% on profit booking on demerger plan of pharma biz

Shareholders of Piramal Enterprises (PEL) will get four shares of Piramal Pharma for every one share in PEL, in addition to their existing holding in PEL

Demerger to give a push to both pharma and financial services: Ajay Piramal

In a Q&A, the Chairman of Piramal Group talks about the prospects of both businesses, the rationale for the demerger and how supply side issues are impacting Indian companies

Demerger could fetch higher valuations for Piramal Pharma

The company is focussing on growth and is scouting for more acquisitions

M-cap of 2 demerged entities could exceed Piramal's by 10-15%: Analysts

Analysts say the demerger will make it easier for investors to value the two companies

Piramal Enterprises board approves to demerge and list pharma business

The demerger will give potential investors the option of being associated with the business of their choice

Piramal Enterprises board approves scheme for pharma business demerger

Piramal Enterprises said shareholders will be issued 4 shares in demerged entity for every 1 held in Piramal Enterprises

Piramal Capital & Housing Finance acquires DHFL via reverse merger

Piramal Enterprises on Friday said its subsidiary, Piramal Capital & Housing Finance Limited (PCHFL), has merged with debt-ridden Dewan Housing Finance (DHFL) after paying Rs 34,250 crore to the creditors of the troubled housing finance company. PCHFL has merged into DHFL with effect from September 30, 2021 pursuant to the reverse merger as contemplated under scheme of arrangement provided under the resolution plan, Piramal Enterprises said in a regulatory filing. "Consequent to the Reverse Merger, DHFL shall issue such number of equity shares to the shareholders of PCHFL i.e. to Piramal Enterprises Limited (PEL), in accordance with the scheme of arrangement provided under the resolution plan," it said. Upon allotment of equity shares to PEL, DHFL will become a wholly-owned subsidiary of PEL, it said, adding, Piramal Enterprises Limited will acquire 100 per cent of the equity share capital in DHFL. "The acquisition is in line with a strategic roadmap to transform and expand ...

DHFL acquisition to see Piramal Enterprises sharpen its retail focus

Completes acquisition; pays Rs 34,250 cr to creditors

Piramal Group acquires DHFL for total consideration of Rs 34,250 cr

The creditors of DHFL will recover an aggregate amount of Rs 38,000 crore from the resolution

India Resurgence Fund invests $75 million in Thrissur Expressway

The Piramal- and Bain Capital-promoted fund will use the money for recasting TEL's existing debt and for last-mile financing to enable project completion

Piramal- Bain fund invests Rs 615 crore in auto component company

Setco Automotive will transfer its clutch business into a subsidiary, Setco Auto Systems into which IndiaRF will invest through a senior debt facility and 35 per cent equity stake in SASPL.

Rally in NBFCs skating on thin ice; Piramal Enterprises biggest gainer

M-cap of top retail NBFCs has risen 19.4% in 2021, against 17.2% rise in Sensex and 12.8% rally in BSE Bankex

Piramal Enterprises hits over 2-year high after strong performance in Q1

In Q1FY22, pharma segment delivered robust revenue growth of 31 per cent YoY, led by the Complex Hospital Generics (CHG) and India Consumer Products (ICP) businesses.